Cerebral PalsyNCT01903616
A Longitudinal Study of Movement and Participation in Life Activities of Young Children With Cerebral Palsy in Taiwan
An observational study of Cerebral Palsy, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
This study investigates the longitudinal course of developmental patterns in movement and participation in life activities (MPLA) of young children with cerebral palsy (CP) in Taiwan. Read more about this study
- Who is it for?
- Ages 3 months to 12 years
- Conditions the study is for
- Cerebral Palsy
- How many people
- 172 participants
- Where
- 1 siteTaiwan
- Study dates
- Jul 2009to Aug 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 months to 12 years
- All sexes
- No healthy volunteers
- Child
Study population: Children with cerebral palsy
Who may be able to join
- diagnosis of CP
Who cannot join
- presence of a progressive neurological disorder or a severe concurrent illness or disease not typically associated with CP, such as traumatic brain injury or active pneumonia
Trial locations and contacts
1 site in 1 country.
About this study
This study investigates the longitudinal course of developmental patterns in movement and participation in life activities (MPLA) of young children with cerebral palsy (CP) in Taiwan. Additionally, the predictors in the initial stage in determining the final developmental patterns in movement and participation in life activities MPLA of these children will be identified.
Read the detailed description
Most researches investigated the longitudinal study of functions in adolescent or adult with CP, however, few researches investigate these functions in children with CP. Knowledge of these developmental patterns in movement and participation in life activities MPLA may be helpful in understanding, anticipating, and managing the problems of these children. We hypothesize that the course of developmental patterns in MPLA of young children with CP evolves with their age. This study investigates the longitudinal course of developmental patterns in MPLA of young children with CP in Taiwan. This study includes a validity and reliability study and a prospective longitudinal study of young children with CP over one-year. This study will be executed in 4 years and a validity and reliability study in the first year.
- Conditions
- Cerebral Palsy
- Medical subject headings
- Cerebral Palsy
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of speech and acoustic variables in 6, 12 and 24 months
Measurement of speech and acoustic variables
Measured: baseline, 6m, 12m, 24 m
Secondary outcomes (8)
Change of range of motion (ROM) in 6, 12 and 24 months
Measurement of ROM
Measured: baseline, 6m, 12m, 24 m
Change of Pediatric Berg Balance Scale (PBS) in 6, 12 and 24 months
Measurement of PBS
Measured: baseline, 6m, 12m, 24 m
Change of spinal Alignment and Range of Motion Measure(SARROM) in 6, 12 and 24 months
Measurement of SARROM
Measured: baseline, 6m, 12m, 24 m
Change of modified ashworth scale(MAS) in 6, 12 and 24 months
Measurement of MAS
Measured: baseline, 6m, 12m, 24 m
Change of cerebral palsy quality of life (CPQOL) in 6, 12 and 24 months
Measurement of CPQOL
Measured: baseline, 6m, 12m, 24 m
Change of TNO-AZL Preschool children Quality of Life (TAPQOL)in 6, 12 and 24 months
Measurement of TAPQOL
Measured: baseline, 6m, 12m, 24 m
Change of Children Assessment of Participation and Enjoyment (CAPE) in 6, 12 and 24 months
Measurement of CAPE
Measured: baseline, 6m, 12m, 24 m
Change of Gross motor function measure (GMFM) in 6, 12 and 24 months
Measurement of GMFM
Measured: baseline, 6m, 12m, 24 m
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2013 (estimated)
- Study startJul 2009
- Primary completionAug 2020
- Study completionAug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral PalsyStudies of the same condition, open and under way.
- More trials run by Chang Gung Memorial HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 172 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- National Science and Technology Council, Taiwan
- Responsible party
- Sponsor
- Investigators
- Chia-Ling Chen, MD,PhD, Study chair, Chang Gung Memorial Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01903616
- Sponsor's protocol ID
- NSC 98-2314-B-182-006-MY3
- Status last verified
- Jan 2020
- First submitted
- 17 Jul 2013
- Last updated
- 24 Aug 2020
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Longitudinal Study of Movement and Participation in Life Activities of Young Children With Cerebral Palsy in Taiwan
- ClinicalTrials.gov ID
- NCT01903616
- Acronym / sponsor ID
- NSC 98-2314-B-182-006-MY3
- Conditions
- Cerebral Palsy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 172 participants (actual)
- Lead sponsor
- Chang Gung Memorial HospitalUniversity, hospital or other
- Collaborators
- National Science and Technology Council, Taiwan
- Study start
- Jul 2009
- Primary completion
- Aug 2020 (actual)
- Study completion
- Aug 2020 (actual)
- First posted
- 19 Jul 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the longitudinal course of developmental patterns in movement and participation in life activities (MPLA) of young children with cerebral palsy (CP) in Taiwan. Additionally, the predictors in the initial stage in determining the final developmental patterns in movement and participation in life activities MPLA of these children will be identified.
Detailed description
Most researches investigated the longitudinal study of functions in adolescent or adult with CP, however, few researches investigate these functions in children with CP. Knowledge of these developmental patterns in movement and participation in life activities MPLA may be helpful in understanding, anticipating, and managing the problems of these children. We hypothesize that the course of developmental patterns in MPLA of young children with CP evolves with their age. This study investigates the longitudinal course of developmental patterns in MPLA of young children with CP in Taiwan. This study includes a validity and reliability study and a prospective longitudinal study of young children with CP over one-year. This study will be executed in 4 years and a validity and reliability study in the first year.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 3 months to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Children with cerebral palsy
Key inclusion criteria (1 listed)
- diagnosis of CP
Key exclusion criteria (1 listed)
- presence of a progressive neurological disorder or a severe concurrent illness or disease not typically associated with CP, such as traumatic brain injury or active pneumonia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Change of speech and acoustic variables in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Measurement of speech and acoustic variables
8 secondary outcomes
Change of range of motion (ROM) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of Pediatric Berg Balance Scale (PBS) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of spinal Alignment and Range of Motion Measure(SARROM) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of modified ashworth scale(MAS) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of cerebral palsy quality of life (CPQOL) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of TNO-AZL Preschool children Quality of Life (TAPQOL)in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of Children Assessment of Participation and Enjoyment (CAPE) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Change of Gross motor function measure (GMFM) in 6, 12 and 24 months
Time frame: baseline, 6m, 12m, 24 m
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Aug 2020.
- Individual participant dataSharing planned: No
Related trials for Cerebral Palsy
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Recruiting
Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP
Diplegic Cerebral Palsy
Recruiting
Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy
Cerebral Palsy
Active, not recruiting
Functional Outcomes and Control Using Synchron BCI - Australia
Neurologic Disorder, Neurologic Diseases
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chia-Ling Chen, MD,PhD study chair
Chang Gung Memorial Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cerebral Palsy, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of speech and acoustic variables in 6, 12 and 24 months (time frame: baseline, 6m, 12m, 24 m). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2020.